These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules. Celani MF, Mariani M, Mariani G. Acta Endocrinol (Copenh); 1990 Dec; 123(6):603-8. PubMed ID: 2284885 [Abstract] [Full Text] [Related]
10. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Silva MN, Rubió IG, Romão R, Gebrin EM, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G. Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994 [Abstract] [Full Text] [Related]
12. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women. Costante G, Crocetti U, Schifino E, Ludovico O, Capula C, Nicotera M, Arturi F, Filetti S. J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240 [Abstract] [Full Text] [Related]
17. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. Puzziello A, Carrano M, Angrisani E, Marotta V, Faggiano A, Zeppa P, Vitale M. J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459 [Abstract] [Full Text] [Related]
18. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Ann Intern Med; 1995 Jan 01; 122(1):1-8. PubMed ID: 7985890 [Abstract] [Full Text] [Related]
19. Short term effects of levothyroxine treatment in thyroid multinodular disease. Cesareo R, Iozzino M, Isgrò MA, Annunziata F, Di Stasio E. Endocr J; 2010 Jan 01; 57(9):803-9. PubMed ID: 20683172 [Abstract] [Full Text] [Related]
20. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F, Rocchi R, Viacava P, Miccoli P, Vitti P. J Clin Endocrinol Metab; 1998 Feb 01; 83(2):492-8. PubMed ID: 9467563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]